4538 — Fuso Pharmaceutical Industries Share Price
0.000.00%
Last trade - 00:00- ¥20bn
- ¥28bn
- ¥55bn
- 31
- 81
- 59
- 62
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.56 | ||
| Price to Tang. Book | 0.57 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.37 | ||
| EV to EBITDA | 6.9 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 3.95% | ||
| Return on Equity | 3.81% | ||
| Operating Margin | 3.29% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ¥m | 46,901 | 49,251 | 49,632 | 51,015 | 55,407 | n/a | n/a | 3.76% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -20.54 | +114.63 | -0.19 | +4.1 | -6.1 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Fuso Pharmaceutical Industries, Ltd. is a Japan-based company principally involved in the manufacture and sale of pharmaceuticals and medical equipment for medical purposes. The Company operates in two business segments. The Pharmaceuticals segment is involved in manufacture and sale of pharmaceutical products, including injectable drugs, which mainly focus on infusion solution, dialysis fluid for artificial kidney, as well as the manufacture and sale of medical equipment and instruments. The Real Estate segment is engaged in the leasing of real estate properties.
Directors
- Mikio Toda PRE (70)
- Yukinobu Matsui CEX (66)
- Yoshikazu Ishii CEX (63)
- Junichi Miyanagi DSL (71)
- Hideki Ohtani DSL
- Takahiko Chigita OTH (69)
- Masanori Ito OTH
- Shuto Naka OTH
- Shokichi Nishimura OTH (65)
- Junichi Oka OTH (64)
- Sadao Takahashi OTH (66)
- Takao Toda OTH (63)
- Last Annual
- March 31st, 2024
- Last Interim
- March 31st, 2024
- Incorporated
- March 25th, 1937
- Public Since
- December 22nd, 1989
- No. of Employees
- 1,314
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Tokyo Stock Exchange
- Shares in Issue
- 8,544,716
- Address
- 1-7-10, Dosho-machi, Chuo-ku, OSAKA-SHI, 541-0045
- Web
- https://www.fuso-pharm.co.jp/
- Phone
- +81 662316887
- Auditors
- Deloitte Touche Tohmatsu LLC
Upcoming Events for 4538
Dividend For 4538.T - 40.0000 JPY
Similar to 4538
ASKA Pharmaceutical Holdings Co
Tokyo Stock Exchange
Astellas Pharma
Tokyo Stock Exchange
Astena Holdings Co
Tokyo Stock Exchange
CanBas Co
Tokyo Stock Exchange
CellSeed
Tokyo Stock Exchange
FAQ
What is the Fuso Pharmaceutical Industries share price?
As of Today at 14:48 UTC, shares in Fuso Pharmaceutical Industries are trading at ¥2,410. This share price information is delayed by 15 minutes.
How has the Fuso Pharmaceutical Industries share price performed this year?
Shares in Fuso Pharmaceutical Industries last closed at ¥2,410 and the price had moved by +21.11% over the past 365 days. In terms of relative price strength the Fuso Pharmaceutical Industries share price has outperformed the Nikkei 225 Index by +2.05% over the past year.
What are the analyst and broker recommendations for Fuso Pharmaceutical Industries?
There is no consensus recommendation for this security.
What is the Fuso Pharmaceutical Industries dividend yield?
The Fuso Pharmaceutical Industries dividend yield is 2.9% based on the trailing twelve month period.
Does Fuso Pharmaceutical Industries pay a dividend?
Last year, Fuso Pharmaceutical Industries paid a total dividend of ¥70, and it currently has a trailing dividend yield of 2.9%.Looking ahead, shares in Fuso Pharmaceutical Industries are due to go ex-dividend on 2024-09-27 and the next dividend pay date is 2024-06-26.
When does Fuso Pharmaceutical Industries next pay dividends?
Fuso Pharmaceutical Industries are due to go ex-dividend on 2024-09-27 and the next dividend pay date is 2024-06-26. The historic dividend yield on Fuso Pharmaceutical Industries shares is currently 2.9%.
How do I buy Fuso Pharmaceutical Industries shares?
To buy shares in Fuso Pharmaceutical Industries you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Fuso Pharmaceutical Industries?
As of the previous close price of ¥2,410, shares in Fuso Pharmaceutical Industries had a market capitalisation of ¥21bn.
Where are Fuso Pharmaceutical Industries shares listed?
Here are the trading details for Fuso Pharmaceutical Industries:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 4538
What kind of share is Fuso Pharmaceutical Industries?
Based on an overall assessment of its quality, value and momentum Fuso Pharmaceutical Industries is currently classified as a Turnaround. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Fuso Pharmaceutical Industries share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Fuso Pharmaceutical Industries share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Fuso Pharmaceutical Industries. Over the past six months, its share price has outperformed the Nikkei 225 Index by +12.04%.
As of the last closing price of ¥2,410, shares in Fuso Pharmaceutical Industries were trading +14.05% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Fuso Pharmaceutical Industries PE Ratio?
The Fuso Pharmaceutical Industries PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at ¥2,410.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Fuso Pharmaceutical Industries?
Fuso Pharmaceutical Industries' management team is headed by:
- Mikio Toda - PRE
- Yukinobu Matsui - CEX
- Yoshikazu Ishii - CEX
- Junichi Miyanagi - DSL
- Hideki Ohtani - DSL
- Takahiko Chigita - OTH
- Masanori Ito - OTH
- Shuto Naka - OTH
- Shokichi Nishimura - OTH
- Junichi Oka - OTH
- Sadao Takahashi - OTH
- Takao Toda - OTH